ISSN: 2767-3774
editor@ijmsphr.com
Articles 2026-05-08 Peer Reviewed

Periodontal Status in Patients with Pulmonary Tuberculosis: Modern Concepts of Pathogenesis and Clinical Manifestations

Nodirkhon Akhrorkhodjaev • Nargiza Parpiyeva • Aliya Kadirbaeva
C R
DOI registered with Crossref
https://doi.org/10.37547/ijmsphr/Volume07Issue05-03
Dimensions Research discovery

Authors

  • Nodirkhon Akhrorkhodjaev
    Fakulty Terapeutic Dentistry Department, PhD, Associate Professor, Tashhkent State Medical University, Tashkent, Uzbekistan
  • Nargiza Parpiyeva
    Director of the Republican Scientific and Practical Medical Center for Phthisiology and Pulmonology, Chief Phthisiatrician of the Republic, MD, Professor. Head of the Department of Phthisiology, Tashhkent State Medical University, Tashkent, Uzbekistan
  • Aliya Kadirbaeva
    Hospital Terapeutic Dentistry Department, MD, Associate Professor, Tashhkent State Medical University, Tashkent, Uzbekistan

Keywords

Pulmonary tuberculosis periodontal diseases periodontitis

Abstract

Pulmonary tuberculosis remains one of the leading infectious diseases worldwide and is accompanied by profound immunological, metabolic, and inflammatory alterations that significantly affect the condition of oral tissues. Numerous investigations indicate that patients with pulmonary tuberculosis demonstrate a high prevalence of inflammatory periodontal diseases, including chronic generalized gingivitis and generalized periodontitis. Immune dysregulation, chronic intoxication, oxidative stress, nutritional deficiencies, smoking, poor oral hygiene, and long-term anti-tuberculosis therapy contribute to periodontal tissue destruction in this category of patients. The present review summarizes contemporary scientific data regarding periodontal status in patients with pulmonary tuberculosis and analyzes the principal pathogenic mechanisms involved in periodontal alterations associated with tuberculosis infection.

Downloads

Download data is not yet available.

References

1
World Health Organization Global Tuberculosis Report 2024. Geneva: World Health Organization; 2024.
2
Bhatnagar S., Gupta N., Gupta A., et al. Oral health status in patients with pulmonary tuberculosis. Journal of Indian Society of Periodontology. 2019;23(4):321–326.
3
Sharma N., Awasthi N., Singh A. Periodontal diseases and systemic health: association with tuberculosis. Journal of Family Medicine and Primary Care. 2020;9(8):4045–4050.
4
Singh A., Gupta A. Periodontal status among patients with pulmonary tuberculosis: a cross-sectional study. Journal of Clinical and Diagnostic Research. 2018;12(7):ZC15–ZC19.
5
Mehta A., Kumar P., Sharma V., et al. Oral manifestations in patients receiving anti-tuberculosis therapy. Indian Journal of Dental Research. 2021;32(2):184–189.
6
Bascones-Martínez A., Muñoz-Corcuera M., Noronha S., et al. Host defence mechanisms against bacterial aggression in periodontal disease: basic mechanisms. Medicina Oral Patología Oral y Cirugía Bucal. 2009;14(12):e680–e685.
7
Kinane D.F., Stathopoulou P.G., Papapanou P.N. Periodontal diseases. Nature Reviews Disease Primers. 2017;3:17038.
8
Nazir M.A. Prevalence of periodontal disease, its association with systemic diseases and prevention. International Journal of Health Sciences. 2017;11(2):72–80.
9
Slots J. Periodontitis: facts, fallacies and the future. Periodontology 2000. 2017;75(1):7–23.
10
Preshaw P.M., Bissett S.M. Periodontitis and diabetes. British Dental Journal. 2019;227(7):577–584.
11
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nature Reviews Immunology. 2015;15(1):30–44.
12
Chapple I.L.C., Genco R. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop. Journal of Clinical Periodontology. 2013;40(S14):S106–S112.
13
Scannapieco F.A., Cantos A. Oral inflammation and infection, and chronic medical diseases: implications for the elderly. Periodontology 2000. 2016;72(1):153–175.
14
Bui F.Q., Almeida-da-Silva C.L.C., Huynh B., et al. Association between periodontal pathogens and systemic disease. Biomedical Journal. 2019;42(1):27–35.
15
Linden G.J., Herzberg M.C.; Working Group 4 of the Joint EFP/AAP Workshop. Periodontitis and systemic diseases: a record of discussions. Journal of Clinical Periodontology. 2013;40(S14):S20–S23.
16
Saini R., Saini S., Sharma S. Periodontitis: a risk for delivery of premature labor and low-birth-weight infants. Journal of Natural Science, Biology and Medicine. 2010;1(1):40–42.
17
Rajan P., Natrajaseenivasan K. Effect of systemic diseases on periodontium. Research Journal of Pharmacy and Technology. 2019;12(6):2958–2962.
18
Kumar P.S. Oral microbiota and systemic disease. Anaerobe. 2013;24:90–93.
19
Tonetti M.S., Greenwell H., Kornman K.S. Staging and grading of periodontitis: framework and proposal of a new classification. Journal of Periodontology. 2018;89(Suppl 1):S159–S172.
20
Scannapieco F.A., Bush R.B., Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. Annals of Periodontology. 2003;8(1):54–69.